Screening | Treatment (post-challenge) | ||||
Pre-challenge | Post-challenge | Placebo | SCH527123 50 mg | Prednisolone | |
Subjects n | 18 | 18 | 18 | 18 | 18 |
Mean# | 72.89 | 31.97 | 35.14 | 76.28 | 56.28 |
Median# | 72.60 | 34.30 | 31.95 | 82.25 | 58.70 |
se# | 3.55 | 2.50 | 3.78 | 3.98 | 3.55 |
Treatment comparison results¶ | |||||
SCH 527123–placebo | 41.07 (51.89–30.25)*** | ||||
Prednisolone–placebo | 20.51 (31.33–9.69)*** |
Data are presented as % or mean difference (95% CI), unless otherwise stated. #: unadjusted (raw) values; ¶: based on ANOVA crossover model with period, treatment, and participant effects (pooled sd: 15.86); ***: p<0.001.